Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dermatology

  Free Subscription


20.03.2017

12 Am J Dermatopathol
2 BMC Cancer
25 Br J Dermatol
2 Cancer
1 Cancer Lett
2 Cancer Res
10 Dermatol Online J
2 Int J Dermatol
6 J Cutan Pathol
4 J Dermatol
3 J Invest Dermatol
2 Lancet Oncol
10 Mycoses
2 N Engl J Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. BROWN MA, Tallon B
    Mitotic Activity in Juvenile Benign Nevi.
    Am J Dermatopathol. 2017;39:187-188.
    PubMed     Text format     Abstract available

  2. YAMAGUCHI S, Miyagi T, Sogabe Y, Yasuda M, et al
    Depletion of Epidermal Langerhans Cells in the Skin Lesions of Pellagra Patients.
    Am J Dermatopathol. 2017 Feb 28. doi: 10.1097/DAD.0000000000000654.
    PubMed     Text format     Abstract available

  3. GROHS RL, Mesbah Ardakani N
    Melanoma Manifesting as Tumoral Melanosis; Now You See It, Now You Don't.
    Am J Dermatopathol. 2017 Feb 28. doi: 10.1097/DAD.0000000000000848.
    PubMed     Text format    

  4. FRINGS VG, Boer-Auer A, Breuer K
    Histomorphology and Immunophenotype of Eczematous Skin Lesions Revisited-Skin Biopsies Are Not Reliable in Differentiating Allergic Contact Dermatitis, Irritant Contact Dermatitis, and Atopic Dermatitis.
    Am J Dermatopathol. 2017 Mar 10. doi: 10.1097/DAD.0000000000000842.
    PubMed     Text format     Abstract available

  5. PATEL TR, Kaffenberger BH, Gru AA
    An Unusual Growth on the Nipple: Question.
    Am J Dermatopathol. 2017;39:195-196.
    PubMed     Text format    

  6. LEE CY, Sholl LM, Zhang B, Merkel EA, et al
    Atypical Spitzoid Neoplasms in Childhood: A Molecular and Outcome Study.
    Am J Dermatopathol. 2017;39:181-186.
    PubMed     Text format     Abstract available

  7. SARAGGI D, Salmaso R, Montesco MC, Zamuner C, et al
    Extraskeletal Myxoid Chondrosarcoma of the Foot Clinically Mimicking Plantar Fibromatosis.
    Am J Dermatopathol. 2017;39:e38-e40.
    PubMed     Text format     Abstract available

  8. OTERO MN, Trujillo CP, Parra-Medina R, Morales SD, et al
    Metastatic Malignant Pilomatrixoma in an 8-Year-Old Girl Misdiagnosed as a Recurrent Pilomatrixoma.
    Am J Dermatopathol. 2017;39:e41-e43.
    PubMed     Text format     Abstract available

  9. TEIXEIRA AI, Soares-Almeida L, Kutzner H
    Agminated Clear Cell Tumor: An Impostor of PEComa and Distinctive Dermal Clear Cell Mesenchymal Neoplasm.
    Am J Dermatopathol. 2017;39:212-216.
    PubMed     Text format     Abstract available

  10. LYNCH MC, Samson TD, Zaenglein AL, Chung CG, et al
    Evolution of Fibroblastic Connective Tissue Nevus in an Infant.
    Am J Dermatopathol. 2017;39:225-227.
    PubMed     Text format     Abstract available

  11. JAYASEKERA P, Bakshi A, Bell HK
    An Unusual Blistering Disorder: Challenge.
    Am J Dermatopathol. 2017;39:197-198.
    PubMed     Text format    

  12. LE MD, O'Steen LH, Cassarino DS
    A Rare Case of CK20/CK7 Double Negative Merkel Cell Carcinoma.
    Am J Dermatopathol. 2017;39:208-211.
    PubMed     Text format     Abstract available


    BMC Cancer

  13. SONG JS, Tawa M, Chau NG, Kupper TS, et al
    Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.
    BMC Cancer. 2017;17:200.
    PubMed     Text format     Abstract available

  14. BHANGOO MS, Zhou JY, Ali SM, Madison R, et al
    Objective response to mTOR inhibition in a metastatic collision tumor of the liver composed of melanoma and adenocarcinoma with TSC1 loss: a case report.
    BMC Cancer. 2017;17:197.
    PubMed     Text format     Abstract available


    Br J Dermatol

  15. ZHENG J
    Absolute Psoriasis Area and Severity Index: an additional evaluation for clinical practice.
    Br J Dermatol. 2017;176:576.
    PubMed     Text format    

  16. YAN J
    Identifying biomarkers in human psoriasis: revealed by a systems metabolomics approach.
    Br J Dermatol. 2017;176:555-557.
    PubMed     Text format    

  17. YIU ZZ
    Psoriasis and increased drug utilization: a true burden of psoriasis or potential surveillance bias of comorbidities?
    Br J Dermatol. 2017;176:566-567.
    PubMed     Text format    

  18. YIU ZZ
    Disease-specific treatment registries for research: psoriasis as an exemplar.
    Br J Dermatol. 2017;176:794-796.
    PubMed     Text format    

  19. GISONDI P
    Could maternal stress increase the risk of developing psoriasis in the offspring?
    Br J Dermatol. 2017;176:569-570.
    PubMed     Text format    

  20. KIVELEVITCH D, Michel P, Menter A
    Quality of life instruments in psoriasis clinical trials.
    Br J Dermatol. 2017;176:563.
    PubMed     Text format    

  21. BURDEN AD
    Etanercept or infliximab for psoriasis? An independent randomized clinical trial.
    Br J Dermatol. 2017;176:565.
    PubMed     Text format    

  22. COATES LC
    Patient education and screening for psoriatic arthritis is key in the care of patients with psoriasis, whichever method is chosen.
    Br J Dermatol. 2017;176:574-575.
    PubMed     Text format    

  23. ATWAN A, Piguet V, Finlay AY, Francis NA, et al
    Dermatology Life Quality Index (DLQI) as a psoriasis referral triage tool.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15446.
    PubMed     Text format     Abstract available

  24. LICCIARDELLO M, T Giura M, Rozzo G, Marra E, et al
    Arrhythmias in metastatic melanoma patient treated with targeted therapy and ICD implant.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15447.
    PubMed     Text format     Abstract available

  25. TAKEICHI T, Kobayashi A, Ogawa E, Okuno Y, et al
    Autosomal dominant familial generalized pustular psoriasis caused by a CARD14 mutation.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15442.
    PubMed     Text format     Abstract available

  26. NABIL R, Bergman W, Kukutsch NA
    Poor agreement between a mobile phone application for the analysis of skin lesions and the clinical diagnosis of the dermatologist, a pilot study.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15443.
    PubMed     Text format     Abstract available

  27. TRABANELLI S
    Indoleamine 2,3-dioxygenase in psoriasis: a defective mechanism.
    Br J Dermatol. 2017;176:570-572.
    PubMed     Text format    

  28. CUST AE, Murrell DF
    Increasing prevalence but not incidence of psoriasis in the U.K.
    Br J Dermatol. 2017;176:568-569.
    PubMed     Text format    

  29. GRIFFITHS CE
    Systems medicine and psoriasis.
    Br J Dermatol. 2017;176:560-562.
    PubMed     Text format    

  30. WIEGELL SR, Petersen B, Wulf HC
    Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial.
    Br J Dermatol. 2016;174:979-84.
    PubMed     Text format     Abstract available

  31. INGRAM JR, Woo PN, Chua SL, Ormerod AD, et al
    Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality.
    Br J Dermatol. 2016;174:970-8.
    PubMed     Text format     Abstract available

  32. WHITTON M, Pinart M, Batchelor JM, Leonardi-Bee J, et al
    Evidence-based management of vitiligo: summary of a Cochrane systematic review.
    Br J Dermatol. 2016;174:962-9.
    PubMed     Text format     Abstract available

  33. HENRY AL, Kyle SD, Chisholm A, Griffiths CE, et al
    A cross-sectional survey of the nature and correlates of sleep disturbance in people with psoriasis.
    Br J Dermatol. 2017 Mar 17. doi: 10.1111/bjd.15469.
    PubMed     Text format     Abstract available

  34. CHAN BC, Stefanato CM, Moonim MT, Morris SL, et al
    Diffuse large B-Cell lymphoma developing in erythrodermic cutaneous T-cell lymphoma: a case series.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15460.
    PubMed     Text format     Abstract available

  35. TEO Y, Walsh S, Creamer D
    Cutaneous Adverse Drug Reactions Referrals to a Liaison Dermatology Service.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15461.
    PubMed     Text format     Abstract available

  36. BLAUVELT A, Griffiths CE, Lebwohl M, Mrowietz U, et al
    Reaching complete or near complete resolution of psoriasis: benefit and risk considerations.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15463.
    PubMed     Text format     Abstract available

  37. INZELBERG R, Friedman E, Azizi E
    Cutaneous squamous cell carcinoma and the PARK2 gene.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15465.
    PubMed     Text format     Abstract available

  38. REICH K, Zschocke I, Bachelez H, de Jong EM, et al
    A Topical Treatment Optimisation Programme (TTOP) improves clinical outcome to calcipotriol/betamethasone gel in psoriasis: Results of the 64-week, multinational, randomized, phase IV study in 1790 patients (PSO-TOP).
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15466.
    PubMed     Text format     Abstract available

  39. REICH A
    Interleukin-17 blockade in generalized pustular psoriasis - new hope for severely ill patients.
    Br J Dermatol. 2017;176:572-573.
    PubMed     Text format    


    Cancer

  40. BJURSTAM NG, Bjorneld LM, Duffy SW
    Updated results of the Gothenburg Trial of Mammographic Screening.
    Cancer. 2016;122:1832-5.
    PubMed     Text format     Abstract available

  41. GUINDALINI RS, Song A, Fackenthal JD, Olopade OI, et al
    Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.
    Cancer. 2016;122:1913-20.
    PubMed     Text format     Abstract available


    Cancer Lett

  42. ANDL T, Zhou L, Yang K, Kadekaro AL, et al
    YAP and WWTR1: New targets for skin cancer treatment.
    Cancer Lett. 2017 Mar 7. pii: S0304-3835(17)30154.
    PubMed     Text format     Abstract available


    Cancer Res

  43. JIANG YZ, Liu YR, Xu XE, Jin X, et al
    Transcriptome analysis of triple-negative breast cancer reveals an integrated mRNA-lncRNA signature with predictive and prognostic value.
    Cancer Res. 2016 Feb 26. pii: canres.3284.2015.
    PubMed     Text format     Abstract available


  44. Correction: Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E.
    Cancer Res. 2017;77:1505.
    PubMed     Text format    


    Dermatol Online J

  45. NGUYEN MA, Rahnama-Moghadam S, Gilson RT
    An uncommon presentation of an uncommon disease: relapsing polychondritis overlap with systemic lupus erythematosus.
    Dermatol Online J. 2016;22.
    PubMed     Text format     Abstract available

  46. MCBRIDE JD, Sontheimer RD
    Proximal nailfold microhemorrhage events are manifested as distal cuticular (eponychial) hemosiderin-containing deposits (CEHD) (syn. Maricq sign) and can aid in the diagnosis of dermatomyositis and systemic sclerosis.
    Dermatol Online J. 2016;22.
    PubMed     Text format     Abstract available

  47. GOZALI MV, Zhou BR, Luo D
    Update on treatment of photodermatosis.
    Dermatol Online J. 2016;22.
    PubMed     Text format     Abstract available

  48. VIDAL D, Ruiz-Villaverde R, Alfageme F, Roustan G, et al
    Use of high frequency ultrasonography in dermatology departments in Spain.
    Dermatol Online J. 2016;22.
    PubMed     Text format     Abstract available

  49. ASHACK KA, Burton KA, Dellavalle RP
    Dermatology in Doximity.
    Dermatol Online J. 2016;22.
    PubMed     Text format     Abstract available

  50. DESMOND BL, Blattner CM, Young Iii J
    Generalized morphea as the first sign of breast carcinoma: a case report.
    Dermatol Online J. 2016;22.
    PubMed     Text format     Abstract available

  51. ALONSO-CORRAL MJ, Garrido-Colmenero C, Martinez-Ortiz F, Ruiz-Villaverde R, et al
    Nevoid hyperkeratosis of the nipple and the areola.
    Dermatol Online J. 2016;22.
    PubMed     Text format     Abstract available

  52. RUIZ-VILLAVERDE R, Sanchez-Cano D, Martinez-Peinado CM, Galan-Gutierrez M, et al
    Verrucous tumor mimicking squamous cell carcinoma in immunocompetent patient.
    Dermatol Online J. 2016;22.
    PubMed     Text format     Abstract available

  53. SONG JS, Halim K, Vleugels RA, Merola JF, et al
    Dapsone for treatment of erythema nodosum.
    Dermatol Online J. 2016;22.
    PubMed     Text format     Abstract available

  54. DEBROY KIDAMBI A, Tiffin NJ, Ramsay HM
    Atypical rosacea in a male patient: case study.
    Dermatol Online J. 2016;22.
    PubMed     Text format     Abstract available


    Int J Dermatol

  55. TSAI WC, Lee CH, Wu WM, Lin SH, et al
    Cutaneous manifestations of subcutaneous and systemic fungal infections in tropical regions: a retrospective study from a referral center in southern Taiwan.
    Int J Dermatol. 2017 Mar 13. doi: 10.1111/ijd.13497.
    PubMed     Text format     Abstract available

  56. CAVIEDES MP, Torre AC, Eliceche ML, Valdivia Monteros DC, et al
    Cutaneous phaeohyphomycosis.
    Int J Dermatol. 2017;56:415-420.
    PubMed     Text format     Abstract available


    J Cutan Pathol

  57. PATEL K, Wu H, Pimpalwar A, Diwan AH, et al
    Response to: CUP-L-003-2017.R1, cutaneous papillary adenocarcinoma in situ.
    J Cutan Pathol. 2017 Mar 16. doi: 10.1111/cup.12919.
    PubMed     Text format    

  58. FRIEDMAN BJ, Dasgeb B, Lee JB
    Cutaneous Crohn disease with superimposed psoriasis: a unique case with overlapping histology.
    J Cutan Pathol. 2017 Mar 14. doi: 10.1111/cup.12928.
    PubMed     Text format     Abstract available

  59. TOMASINI C, Moneghini L, Barbui Anna M
    Chronic Amastigote-Negative cutaneous leishmaniasis. A clinical, histopathologic and molecular study of 27 cases with emphasis on atypical and pseudolymphomatous presentations.
    J Cutan Pathol. 2017 Mar 10. doi: 10.1111/cup.12927.
    PubMed     Text format     Abstract available

  60. XU J, Tahan S, Jan F, Do D, et al
    Nail dystrophy as the initial sign of multiple myeloma-associated systemic amyloidosis.
    J Cutan Pathol. 2016;43:543-5.
    PubMed     Text format    

  61. WOHLTMANN WE, Sperling L
    Histopathologic diagnosis of multifactorial alopecia.
    J Cutan Pathol. 2016;43:483-91.
    PubMed     Text format     Abstract available

  62. MANCEBO SE, Cordova M, Myskowski PL, Flores ES, et al
    Reflectance confocal microscopy features of mycosis fungoides and Sezary syndrome: correlation with histopathologic and T-cell receptor rearrangement studies.
    J Cutan Pathol. 2016;43:505-15.
    PubMed     Text format     Abstract available


    J Dermatol

  63. YAMANAKA K, Yamagiwa A, Akeda T, Kondo M, et al
    Neutrophils are not the dominant interleukin-17 producer in psoriasis.
    J Dermatol. 2017 Mar 11. doi: 10.1111/1346-8138.13807.
    PubMed     Text format    

  64. SUH HY, Ahn JY, Park MY, Youn JI, et al
    Exacerbation of infliximab-induced paradoxical psoriasis after ustekinumab therapy.
    J Dermatol. 2017 Mar 11. doi: 10.1111/1346-8138.13803.
    PubMed     Text format    

  65. MIYAZAWA H, Yanagi T, Yamaguchi Y, Imafuku K, et al
    Two cases of melanomas paradoxically metastasizing to the intestinal tract during nivolumab therapy.
    J Dermatol. 2017 Mar 11. doi: 10.1111/1346-8138.13825.
    PubMed     Text format     Abstract available

  66. WASHIO K, Sumi M, Nakata K, Fukunaga A, et al
    Case of harlequin ichthyosis with a favorable outcome: Early treatment and novel, differentially expressed, alternatively spliced transcripts of the ATP-binding cassette subfamily A member 12 gene.
    J Dermatol. 2017 Mar 11. doi: 10.1111/1346-8138.13823.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  67. BISSONNETTE R, Harel F, Krueger JG, Guertin MC, et al
    TNF-alpha antagonist and vascular inflammation in patients with psoriasis vulgaris: a randomized placebo-controlled study.
    J Invest Dermatol. 2017 Mar 9. pii: S0022-202X(17)31213.
    PubMed     Text format     Abstract available

  68. CALCATERRA F, Brambilla L, Colombo E, Tourlaki A, et al
    Increased frequency and vasculogenic potential of endothelial colony-forming cells in patients with Kaposi's sarcoma.
    J Invest Dermatol. 2017 Mar 10. pii: S0022-202X(17)31215.
    PubMed     Text format     Abstract available

  69. FU W, Yi S, Qiu L, Sun J, et al
    BCL11B Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma.
    J Invest Dermatol. 2017 Mar 10. pii: S0022-202X(17)31216.
    PubMed     Text format     Abstract available


    Lancet Oncol

  70. POSTOW MA, Chapman PB
    A step forward for patients with NRAS-mutant melanoma.
    Lancet Oncol. 2017 Mar 8. pii: S1470-2045(17)30172.
    PubMed     Text format    

  71. DUMMER R, Schadendorf D, Ascierto PA, Arance A, et al
    Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.
    Lancet Oncol. 2017 Mar 8. pii: S1470-2045(17)30180.
    PubMed     Text format     Abstract available


    Mycoses

  72. MACCIONI F, Vetere S, De Felice C, Al Ansari N, et al
    Pulmonary fungal infections in patients with acute myeloid leukaemia: is it the time to revise the radiological diagnostic criteria?
    Mycoses. 2016;59:357-64.
    PubMed     Text format     Abstract available

  73. VAEZI A, Moazeni M, Rahimi MT, de Hoog S, et al
    Mucormycosis in Iran: a systematic review.
    Mycoses. 2016;59:402-15.
    PubMed     Text format     Abstract available

  74. SCHALLER M, Friedrich M, Papini M, Pujol RM, et al
    Topical antifungal-corticosteroid combination therapy for the treatment of superficial mycoses: conclusions of an expert panel meeting.
    Mycoses. 2016;59:365-73.
    PubMed     Text format     Abstract available

  75. CHANG H, Ashu E, Sharma C, Kathuria S, et al
    Diversity and origins of Indian multi-triazole resistant strains of Aspergillus fumigatus.
    Mycoses. 2016;59:450-66.
    PubMed     Text format     Abstract available

  76. PREISSNER S, Kastner I, Schutte E, Hartwig S, et al
    Adjuvant antifungal therapy using tissue tolerable plasma on oral mucosa and removable dentures in oral candidiasis patients: a randomised double-blinded split-mouth pilot study.
    Mycoses. 2016;59:467-75.
    PubMed     Text format     Abstract available

  77. DIDEHDAR M, Khansarinejad B, Amirrajab N, Shokohi T, et al
    Development of a high-resolution melting analysis assay for rapid and high-throughput identification of clinically important dermatophyte species.
    Mycoses. 2016;59:442-9.
    PubMed     Text format     Abstract available

  78. MASHIAH J, Kutz A, Ben Ami R, Savion M, et al
    Tinea capitis outbreak among paediatric refugee population, an evolving healthcare challenge.
    Mycoses. 2016;59:553-7.
    PubMed     Text format     Abstract available

  79. BOMBACE F, Iovene MR, Galdiero M, Martora F, et al
    Non-dermatophytic onychomycosis diagnostic criteria: an unresolved question.
    Mycoses. 2016;59:558-65.
    PubMed     Text format     Abstract available

  80. PCHELIN IM, Zlatogursky VV, Rudneva MV, Chilina GA, et al
    Reconstruction of phylogenetic relationships in dermatomycete genus Trichophyton Malmsten 1848 based on ribosomal internal transcribed spacer region, partial 28S rRNA and beta-tubulin genes sequences.
    Mycoses. 2016;59:566-75.
    PubMed     Text format     Abstract available

  81. REZUSTA A, de la Fuente S, Gilaberte Y, Vidal-Garcia M, et al
    Evaluation of incubation time for dermatophytes cultures.
    Mycoses. 2016;59:416-8.
    PubMed     Text format     Abstract available


    N Engl J Med

  82. MENNINI M, Dahdah L, Fiocchi A
    Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
    N Engl J Med. 2017;376:1090.
    PubMed     Text format    


  83. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
    N Engl J Med. 2017;376:1090-1.
    PubMed     Text format    


    PLoS One

  84. BLOKZIJL A, Chen LE, Gustafsdottir SM, Vuu J, et al
    Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.
    PLoS One. 2016;11:e0154214.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: